ID

14127

Descripción

Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT02328755

Link

https://clinicaltrials.gov/show/NCT02328755

Palabras clave

Versiones (1)
  1. 30/3/16 30/3/16 -
Subido en

30 de marzo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Acute Myeloid Leukemia NCT02328755

Inglés

Eligibility Acute Myeloid Leukemia NCT02328755

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient must have aml not in remission or at very high risk for hct (hematopoietic cell transplantation) relapse.
Descripción

AML

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0153886
for newly diagnosed aml, patients must have achieved two consecutive induction attempts without achieving complete remission
Descripción

induction attempts

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514832
for patients initially in complete remission whose aml relapses > 6 months after preceding remission, one re-induction must be attempted to be eligible
Descripción

aml relapse

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2367456
for aml patients with early relapse, in whom the preceding remission is shorter than 6 months duration, no re-induction regimen is necessary to be eligible
Descripción

re-induction regimen

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0153886
patients with antecedent mds (myelodysplastic syndrome) who progress to aml may have therapies rendered during both phases counted towards these requirements.
Descripción

MYELODYSPLASTIC SYNDROME

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3463824
availability of an 8/8 matched donor at a, b, c, and dr loci. mismatch at hla dq are permissible. matched related or unrelated donors are acceptable peripheral blood or bone marrow stem cells are acceptable
Descripción

matched donor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0150103
patients must be ≥ 18 years of age and considered a candidate for hct
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
karnofsky ≥ 70%
Descripción

karnofsky performance status is measure of a cancer patients general well being and activities of daily life. scores range from 100 to 0 where 100 is perfect health and 0 is death

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
patients must meet acceptable organ function criteria: total bilirubin ≤2.5 mg, ast (aspartate transaminase) and alt (alanine transaminase) <5.0 x institutional upper limit of normal; gfr (glomerular filtration rate) >40 ml/min/1.73 m2 for patients with creatinine levels above institutional normal; lung function tests (dlco, fev1, fvc) > 50%; ejection fraction > 50%
Descripción

acceptable organ function

Tipo de datos

integer

Alias
UMLS CUI [1]
C1254358
written informed consent
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
women and men of child-bearing potential must agree to use adequate contraception
Descripción

contraception

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy treatment for aml within 21 days from the initiation of hct conditioning
Descripción

chemotherapy treatment for aml

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3665472
patients may not have evidence or symptoms of cns disease at the time of enrollment
Descripción

CNS disorder

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007682
hiv or htlv1 / htlv2 (human t-lymphotrophic virus) (seropositivity and/or pcr positivity)
Descripción

HIV+, htlv1

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C0020094
patients less than 18 years of age
Descripción

Less than age 18

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3261299
pregnant and nursing mothers are excluded from this study
Descripción

pregnant

Tipo de datos

boolean

patients with untreated or uncontrolled neuropsychiatric illness
Descripción

neuropsychiatric illness

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3203509
any physical or psychological condition that, in the opinion of the investigator, would pose unacceptable risk to the patient
Descripción

risk to the patient

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0525058
uncontrolled infections
Descripción

Communicable Diseases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
Volver a la parte superior de la página

Similar models

Eligibility Acute Myeloid Leukemia NCT02328755

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
AML
Item
patient must have aml not in remission or at very high risk for hct (hematopoietic cell transplantation) relapse.
boolean
C0153886 (UMLS CUI [1])
induction attempts
Item
for newly diagnosed aml, patients must have achieved two consecutive induction attempts without achieving complete remission
boolean
C1514832 (UMLS CUI [1])
aml relapse
Item
for patients initially in complete remission whose aml relapses > 6 months after preceding remission, one re-induction must be attempted to be eligible
boolean
C2367456 (UMLS CUI [1])
re-induction regimen
Item
for aml patients with early relapse, in whom the preceding remission is shorter than 6 months duration, no re-induction regimen is necessary to be eligible
boolean
C0153886 (UMLS CUI [1])
MYELODYSPLASTIC SYNDROME
Item
patients with antecedent mds (myelodysplastic syndrome) who progress to aml may have therapies rendered during both phases counted towards these requirements.
boolean
C3463824 (UMLS CUI [1])
matched donor
Item
availability of an 8/8 matched donor at a, b, c, and dr loci. mismatch at hla dq are permissible. matched related or unrelated donors are acceptable peripheral blood or bone marrow stem cells are acceptable
boolean
C0150103 (UMLS CUI [1])
age
Item
patients must be ≥ 18 years of age and considered a candidate for hct
boolean
C0001779 (UMLS CUI [1])
karnofsky performance status
Item
karnofsky ≥ 70%
boolean
C0206065 (UMLS CUI [1])
Item
patients must meet acceptable organ function criteria: total bilirubin ≤2.5 mg, ast (aspartate transaminase) and alt (alanine transaminase) <5.0 x institutional upper limit of normal; gfr (glomerular filtration rate) >40 ml/min/1.73 m2 for patients with creatinine levels above institutional normal; lung function tests (dlco, fev1, fvc) > 50%; ejection fraction > 50%
integer
C1254358 (UMLS CUI [1])
acceptable organ function
Code List
patients must meet acceptable organ function criteria: total bilirubin ≤2.5 mg, ast (aspartate transaminase) and alt (alanine transaminase) <5.0 x institutional upper limit of normal; gfr (glomerular filtration rate) >40 ml/min/1.73 m2 for patients with creatinine levels above institutional normal; lung function tests (dlco, fev1, fvc) > 50%; ejection fraction > 50%
CL Item
total bilirubin ≤2.5 mg (1)
C0201913 (UMLS CUI-1)
CL Item
ast/alt 5.0 x institutional upper limit of normal (2)
C0201913 (UMLS CUI-1)
CL Item
gfr (glomerular filtration rate) >40  (3)
C0017654 (UMLS CUI-1)
CL Item
lung function tests (dlco, fev1, fvc) (4)
C0024119 (UMLS CUI-1)
informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
contraception
Item
women and men of child-bearing potential must agree to use adequate contraception
boolean
C0700589 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
chemotherapy treatment for aml
Item
prior chemotherapy treatment for aml within 21 days from the initiation of hct conditioning
boolean
C3665472 (UMLS CUI [1])
CNS disorder
Item
patients may not have evidence or symptoms of cns disease at the time of enrollment
boolean
C0007682 (UMLS CUI [1])
HIV+, htlv1
Item
hiv or htlv1 / htlv2 (human t-lymphotrophic virus) (seropositivity and/or pcr positivity)
boolean
C0019699 (UMLS CUI [1])
C0020094 (UMLS CUI [2])
Less than age 18
Item
patients less than 18 years of age
boolean
C3261299 (UMLS CUI [1])
pregnant
Item
pregnant and nursing mothers are excluded from this study
boolean
neuropsychiatric illness
Item
patients with untreated or uncontrolled neuropsychiatric illness
boolean
C3203509 (UMLS CUI [1])
risk to the patient
Item
any physical or psychological condition that, in the opinion of the investigator, would pose unacceptable risk to the patient
boolean
C0525058 (UMLS CUI [1])
Communicable Diseases
Item
uncontrolled infections
boolean
C0009450 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial